Mechanistically, we showed that H19 promoted hepatic steatosis by up‐regulating MLXIPL/ChREBP and silencing Mlxipl diminished H19‐induced lipid accumulation in hepatocytes. Here, MLXIPL is linked to fatty liver disease.